Effect of double inhaled corticosteroids in patients with moderate bronchial asthma

Effect of double inhaled corticosteroids in patients with moderate bronchial asthma - Double inhaled corticosteroids on moderate bronchial asthma

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000002657

Enrollment

Registered

2009-11-01

Start date

2009-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bronchial asthma

Interventions

Adoair 500 micro g + Asmanex 200 micro g Adoair 1000 micro g

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with uncontroled moderate asthma treated with Adoair 250 micro g twice a day.

Exclusion criteria

Exclusion criteria: Cronic disease such as COPD. Acute disease such as infectious disease.

Design outcomes

Primary

Measure	Time frame
exhaled NO	—

Secondary

Measure	Time frame
pulmonary functions and peak flow	—

Countries

Japan

Contacts

Public ContactKazuyoshi Kurashima

Saitama cardiovascular and respiratory center respiratory medicine

kurashima.kazuyoshi@pref.saitama.lg.jp048-536-9900

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026